Structures by: Glidewell C.
Total: 1 449
3,5-Dinitrobenzoic acid--N,N,N',N'-tetramethylethylenediamine (2/1)
2(C7H3N2O6),C6H18N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=6.0665(2)Å b=9.0635(3)Å c=21.8452(6)Å
α=90.00° β=92.031(2)° γ=90.00°
3,5-Dinitrobenzoic acid--N,N'-dimethylpiperazine (2/1)
2(C7H3N2O6),C6H16N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=7.1399(2)Å b=21.1749(6)Å c=7.8255(2)Å
α=90.00° β=99.1990(18)° γ=90.00°
3,5-Dinitrobenzoic acid--1,2-bis(4'-pyridyl)ethane (2/1)
C12H13N2,C14H7N4O12
Acta Crystallographica Section B (2001) 57, 2 201-212
a=10.1344(6)Å b=4.9420(2)Å c=27.5984(14)Å
α=90.00° β=110.960(2)° γ=90.00°
3,5-Dinitrobenzoic acid--trans-1,2-bis(4'-pyridyl)ethene (2/1)
C12H12N2,2(C7H3N2O6)
Acta Crystallographica Section B (2001) 57, 2 201-212
a=4.7297(3)Å b=9.3973(6)Å c=14.8365(6)Å
α=104.528(3)° β=94.086(3)° γ=92.793(3)°
Piperazinee--3,5-dihydroxybenzoic acid--water (1/2/4)
C4H12N2,2(C7H5O4),4(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=7.7793(3)Å b=8.1656(3)Å c=9.0662(4)Å
α=104.981(2)° β=97.134(2)° γ=98.066(2)°
1,2-Diaminoethane--3,5-dihydroxybenzoic acid--water (1/2/2)
C2H10N2,2(C7H5O4),2(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=8.0804(3)Å b=10.6021(6)Å c=11.3988(6)Å
α=90.00° β=109.243(3)° γ=90.00°
Triaqua-N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidine-2-yl) glycinatolithium,
C7H14LiN5O7
Acta Crystallographica Section B (2001) 57, 3 317-328
a=24.7736(6)Å b=7.6525(3)Å c=14.0096(5)Å
α=90.00° β=114.3751(13)° γ=90.00°
Aqua-N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4- oxopyrimidin-2-yl)glycinatopotassium
C7H10KN5O5
Acta Crystallographica Section B (2001) 57, 3 317-328
a=7.8114(2)Å b=16.4811(5)Å c=8.5560(2)Å
α=90.00° β=100.408(2)° γ=90.00°
Tetraaqua-bis[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4- oxopyrimidin-2-yl)glycinato]manganese(II) hexahydrate
C14H24MnN10O12,6(H2O)
Acta Crystallographica Section B (2001) 57, 3 317-328
a=7.4476(3)Å b=8.2351(4)Å c=12.6372(5)Å
α=105.258(2)° β=92.153(3)° γ=108.94(2)°
N-phenylpyrazinecarboxamide
C11H9N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9716(3)Å b=7.5270(4)Å c=11.0318(6)Å
α=83.295(3)° β=85.377(4)° γ=69.009(3)°
N-(2-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=15.5361(9)Å b=7.0360(3)Å c=18.9863(9)Å
α=90.00° β=91.307(2)° γ=90.00°
N-(4-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.0039(3)Å b=5.6916(2)Å c=13.3466(3)Å
α=90.00° β=101.6381(12)° γ=90.00°
N-(3-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.2736(4)Å b=10.8639(4)Å c=18.5040(5)Å
α=90.00° β=90.1970(19)° γ=90.00°
N-(2-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.6748(3)Å b=7.8967(3)Å c=9.8421(5)Å
α=96.682(2)° β=103.357(3)° γ=101.659(2)°
N-(4-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8885(6)Å b=7.5257(9)Å c=13.2762(16)Å
α=78.349(7)° β=86.460(8)° γ=70.146(8)°
N-(4-fluorophenyl)pyrazinecarboxamide, P2~1~/c polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=11.718(2)Å b=5.9726(10)Å c=13.474(2)Å
α=90.00° β=91.446(9)° γ=90.00°
N-(3-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.9121(3)Å b=10.9457(3)Å c=18.6827(4)Å
α=90.00° β=92.026(2)° γ=90.00°
N-(4-fluorophenyl)pyrazinecarboxamide, Pc polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9666(3)Å b=24.2205(15)Å c=13.0262(7)Å
α=90.00° β=91.720(3)° γ=90.00°
N-(2-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.1667(4)Å b=20.7513(6)Å c=7.4516(3)Å
α=90.00° β=90.00° γ=90.00°
N-(3-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2,H2O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.9386(2)Å b=8.5820(3)Å c=19.0670(6)Å
α=90.00° β=99.394(2)° γ=90.00°
N-(2-nitrophenyl)pyrazinecarboxamide?
C11H8N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=3.6598(2)Å b=21.7123(17)Å c=13.1158(10)Å
α=90.00° β=91.281(5)° γ=90.00°
N-(2,6-dimethylphenyl)pyrazinecarboxamide
C13H13N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.3977(4)Å b=10.7671(5)Å c=15.2457(4)Å
α=90.00° β=101.665(3)° γ=90.00°
N-(2-chloro-4-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=18.733(4)Å b=3.8502(8)Å c=14.839(3)Å
α=90.00° β=99.472(3)° γ=90.00°
N-(4-chloro-2-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.8885(2)Å b=10.5369(5)Å c=14.6683(7)Å
α=90.00° β=99.008(3)° γ=90.00°
8-methyl-7-(4-chlorophenyl)-10-phenyl-6,10-dihydro- 5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=12.1072(4)Å b=14.2672(5)Å c=12.7635(4)Å
α=90.00° β=109.953(8)° γ=90.00°
8-methyl-7-(3-pyridinyl)-10-phenyl-6,10- dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.2274(6)Å b=13.7079(8)Å c=12.6935(7)Å
α=90.00° β=95.731(3)° γ=90.00°
11-(3,4,5-trimethoxyphenyl)-10-methyl-8-phenyl-6,8- dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
C30H27N3O3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=10.4716(9)Å b=20.0027(18)Å c=12.1529(9)Å
α=90.00° β=107.818(4)° γ=90.00°
8-methyl-7-(4-pyridinyl)-10-phenyl-10H- benzo[h]pyrazolo[3,4-b]quinoline
C26H18N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.3560(3)Å b=17.3507(5)Å c=9.7577(2)Å
α=90.00° β=97.262(2)° γ=90.00°
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section B (2008) 64, 1 72-83
a=18.0854(3)Å b=21.2296(5)Å c=23.8007(5)Å
α=90.00° β=108.2580(10)° γ=90.00°
11-(4-methylphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.1334(3)Å b=11.4672(2)Å c=17.6270(4)Å
α=97.858(2)° β=106.135(3)° γ=97.496(2)°
1,4-Diazabicyclo[2.2.2]octane--phosphonoacetic acid (1/1)
C6H12N2,C2H5O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=20.3011(17)Å b=6.7692(5)Å c=8.0158(6)Å
α=90.00° β=90.00° γ=90.00°
2,2'-Dipyridylamine--fumaric acid (1/1)
C10H10N3,C4H3O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=8.0021(4)Å b=8.7178(4)Å c=10.8497(4)Å
α=106.257(3)° β=109.127(3)° γ=98.662(2)°
2,2'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=23.9702(6)Å b=3.74160(10)Å c=14.8372(4)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid
C10H16O4
Acta Crystallographica Section B (2003) 59, 1 118-131
a=7.7206(3)Å b=11.6677(5)Å c=12.5830(5)Å
α=90.00° β=105.653(2)° γ=90.00°
2-Amino-6-benzyloxy-4-(N-methylamino)-5-nitrosopyrimidine
C12H13N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.1122(2)Å b=7.3873(2)Å c=23.3867(7)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-6-benzyloxy-4-(N-butylamino)-5-nitrosopyrimidine
C15H19N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.6146(2)Å b=13.7686(4)Å c=16.1215(5)Å
α=90.00° β=116.6180(15)° γ=90.00°
2-Amino-6-benzyloxy-4-(N-dodecylamino)-5-nitrosopyrimidine
C23H35N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.3567(4)Å b=7.7784(4)Å c=21.4725(14)Å
α=92.000(2)° β=99.840(2)° γ=108.760(2)°
2-amino-6-benzyloxy-4-(N-cyclohexylamino)-5-nitrosopyrimidine
C17H21N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=8.2656(5)Å b=10.6077(6)Å c=10.6743(7)Å
α=64.841(4)° β=71.021(3)° γ=87.275(5)°
2-Amino-6-benzyloxy-4-piperidino-5-nitrosopyrimidine monohydrate
C16H19N5O2,H2O
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.2557(4)Å b=11.4692(7)Å c=20.4417(15)Å
α=90.00° β=106.113(3)° γ=90.00°
2-Amino-6-benzyloxy-4-piperidino-pyrimidine
C16H20N4O
Acta Crystallographica Section B (2003) 59, 2 263-276
a=6.5025(2)Å b=11.8006(4)Å c=20.7673(10)Å
α=76.1950(14)° β=82.3623(14)° γ=77.330(4)°
2-Amino-4-(N-butylamino)-6-(3-pyridyl)methoxy-5-nitrosopyrimidine
C14H18N6O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=28.3925(6)Å b=8.1627(3)Å c=15.1540(5)Å
α=90.00° β=121.9700(13)° γ=90.00°
Triphenylsilanol--4,4-bipyridyl (1/1)
C18H16OSi,C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=8.9849(3)Å b=9.3118(4)Å c=15.2451(7)Å
α=83.2841(18)° β=89.1384(17)° γ=64.6930(10)°
2,6-Dimethylpiperazine--phosphonopropionic acid--methanol (1/2/0.34)
C6H16N22,2(C3H6O5P1),0.3(CH4O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=20.2229(17)Å b=8.6162(6)Å c=11.8812(9)Å
α=90.00° β=90.00° γ=90.00°
4,4'-Bipyridyl--phosphonoacetic acid (1/1)
C10H9N2,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=4.6225(2)Å b=17.2421(6)Å c=15.6529(7)Å
α=90.00° β=95.7190(15)° γ=90.00°
Meso-5,5,7,12,12,14-Hexa-C-methyl-1,4,8,11- tetraazacyclotetradecane--phosphonoacetic acid (1/2)
C16H38N4,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.7219(2)Å b=9.89470(10)Å c=9.9343(2)Å
α=62.5110(9)° β=85.6800(8)° γ=67.1910(9)°
2,2'-Dipyridylamine--phosphonoacetic acid (1/1)
C10H10N3,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=7.0706(2)Å b=10.6500(3)Å c=10.7020(4)Å
α=115.8690(13)° β=98.8120(15)° γ=104.0040(13)°
1,2-Bis(4'-pyridyl)ethane--phosphonoacetic acid (1/2)
C12H14N2,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.8501(3)Å b=15.1862(6)Å c=7.3741(3)Å
α=90.00° β=90.761(2)° γ=90.00°
1,2-Bis(4-pyridyl)ethane--maleic acid (1/2)
C12H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=5.7958(3)Å b=9.4489(6)Å c=9.6031(7)Å
α=86.787(3)° β=73.010(3)° γ=76.986(3)°
4,4'-Bipyridyl--maleic acid (1/2)
C10H10N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=24.0370(16)Å b=6.7434(6)Å c=11.4388(10)Å
α=90.00° β=115.996(4)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/2)
C6H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=20.1118(9)Å b=6.4737(4)Å c=12.5409(7)Å
α=90.00° β=115.070(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/1)
C6H13.57N2,C4H2.43O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=9.6845(2)Å b=8.8805(2)Å c=12.5886(2)Å
α=90.00° β=100.0697(15)° γ=90.00°
4,4'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=3.8040(2)Å b=8.8743(5)Å c=9.8764(6)Å
α=109.757(2)° β=97.246(3)° γ=96.813(3)°
1,2-Bis(4-pyridyl)ethane--fumaric acid (1/1)
C12H12N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=21.0296(14)Å b=4.7456(3)Å c=16.6875(11)Å
α=90.00° β=118.394(3)° γ=90.00°
4,4'-trimethylenedipyridine--fumaric acid (1/1)
C13H14N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=22.4349(15)Å b=4.6045(3)Å c=17.1156(12)Å
α=90.00° β=116.465(3)° γ=90.00°
2,2'-Dipyridylamine--maleic acid (1/2)
C10H10N3,C8H7O8
Acta Crystallographica Section B (2003) 59, 1 100-117
a=11.566(2)Å b=5.4392(11)Å c=14.334(3)Å
α=90.00° β=99.03(3)° γ=90.00°
Hexamethylenetetramine--fumaric acid--succinic acid (1/0.726/0.224)
C6H12N4,0.726(C4H4O4),0.274(C4H6O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=6.2877(2)Å b=15.9241(6)Å c=11.3315(5)Å
α=90.00° β=93.8556(13)° γ=90.00°
(1R,3S)-Camphoric acid--1,4-diazabicyclo[2.2.2]octane--water (1/1/1)
C6H13N2,C10H15O4,H2O
Acta Crystallographica Section B (2003) 59, 1 118-131
a=7.0310(3)Å b=11.2520(5)Å c=21.8177(12)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid--hexamethylenetetramine (2/1)
2(C10H16O4),C6H12N4
Acta Crystallographica Section B (2003) 59, 1 118-131
a=19.9172(8)Å b=6.7515(3)Å c=10.6272(4)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid--1,2-bis(4-pyridyl)ethane (1/1)
C12H12N2,C10H16O4
Acta Crystallographica Section B (2003) 59, 1 118-131
a=8.5318(2)Å b=10.3775(2)Å c=23.3884(5)Å
α=99.8190(8)° β=95.4780(8)° γ=90.7870(9)°
(1R,3S)-Camphoric acid--N,N'-dimethylpiperazine--water (3/1/2)
C10H16O4,2(C10H15O4),(C6H16N2),2H2O
Acta Crystallographica Section B (2003) 59, 1 118-131
a=13.5730(4)Å b=22.0500(8)Å c=6.8417(2)Å
α=90.00° β=90.00° γ=90.00°
1,2-Bis(4'-pyridyl)ethene--phosphonopropionic acid (1/1)
C12H12N22,C12H10N2,2(C3H6O5P)1
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.1600(3)Å b=10.4061(3)Å c=14.5441(5)Å
α=90.00° β=96.2880(12)° γ=90.00°
2,2'-Dipyridylamine--phosphonopropionic acid--water (1/1/1)
C10H10N31,C3H6O5P1,H2O
Acta Crystallographica Section B (2003) 59, 2 248-262
a=18.7267(11)Å b=22.6805(11)Å c=7.0893(4)Å
α=90.00° β=90.00° γ=90.00°
Piperazine--phosphonopropionic acid (1/1)
C4H12N22,C3H5O5P2
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.6065(3)Å b=7.9214(2)Å c=12.8892(4)Å
α=90.00° β=94.0540(12)° γ=90.00°
N,N'-Dimethylpiperazine--phosphonopropionic acid--water (1/2/2)
C6H16N22,2(C3H6O5P1),2(H2O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=6.9270(2)Å b=20.6027(5)Å c=8.0115(2)Å
α=90.00° β=111.4092(10)° γ=90.00°
4,4'-Bipyridyl--phosphonopropionic acid (1/1)
C10H8.82N20.72,C3H6O5.28P0.72=
Acta Crystallographica Section B (2003) 59, 2 248-262
a=11.3482(5)Å b=6.7178(3)Å c=17.7354(7)Å
α=90.00° β=97.4980(18)° γ=90.00°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 0.5
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=9.2128(18)Å b=10.244(2)Å c=19.036(4)Å
α=99.65(3)° β=93.21(3)° γ=99.57(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 1
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=10.1595(19)Å b=18.370(4)Å c=20.490(4)Å
α=66.75(3)° β=77.35(3)° γ=80.95(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 4
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=20.787(4)Å b=24.404(5)Å c=29.456(6)Å
α=83.68(3)° β=89.65(3)° γ=67.11(3)°
(1R,3S)-Camphoric acid--4,4'-bipyridyl (1/1)
C10H16O4,C10H8N2
Acta Crystallographica Section B (2003) 59, 1 118-131
a=6.7302(10)Å b=6.7302(10)Å c=34.345(7)Å
α=90.00° β=90.00° γ=120.00°
1,2-Bis(4'-pyridyl)ethane--phosphonopropionic acid (1/2)
C12H14N22,2(C3H6O5P1)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=7.5651(3)Å b=8.6472(3)Å c=9.0077(4)Å
α=72.6340(14)° β=73.1760(15)° γ=87.386(2)°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Cc polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.8443(2)Å b=22.7344(16)Å c=11.4216(8)Å
α=90.00° β=97.636(4)° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Pbcn polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=22.2727(3)Å b=8.2207(4)Å c=13.5916(7)Å
α=90.00° β=90.00° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, P2~1~ polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=6.1515(9)Å b=4.7875(5)Å c=20.748(3)Å
α=90.000° β=97.540(7)° γ=90.000°
1-(2-chloronicotinoyl)-2-(3-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=9.0691(3)Å b=19.6472(5)Å c=7.4302(3)Å
α=90.00° β=110.424(2)° γ=90.00°
1-(2-chloronicotinoyl)-2-(4-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.58110(10)Å b=24.8913(13)Å c=11.2782(6)Å
α=90.00° β=94.095(3)° γ=90.00°
2-Iodo-5-nitro-aniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=6.4236(15)Å b=7.4979(18)Å c=8.293(2)Å
α=71.422(4)° β=85.285(4)° γ=86.125(4)°
4-Iodo-2-nitroaniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=26.5541(9)Å b=7.0445(2)Å c=16.4416(5)Å
α=90.00° β=101.1548(16)° γ=90.00°
1-Ferrocenyl-1,2-diphenylethanol
C24H22FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=26.229(2)Å b=5.889(2)Å c=24.553(2)Å
α=90.0° β=104.114(11)° γ=90.0°
C21H24FeO
C21H24FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=8.007(4)Å b=13.002(2)Å c=66.240(10)Å
α=90° β=91.96(3)° γ=90°
1-Ferrocenylethanol
C12H14FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=23.3334(18)Å b=23.3334(18)Å c=7.7186(11)Å
α=90.0° β=90.0° γ=90.0°
1-Ferrocenyl-2-phenylethanol
C18H18FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=9.8589(7)Å b=15.2800(17)Å c=19.1399(17)Å
α=90.0° β=90.0° γ=90.0°
1-Ferrocenyl-1-phenylpropan-1-ol
C19H20FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=10.2443(13)Å b=10.5811(17)Å c=14.2487(12)Å
α=90.0° β=100.190(9)° γ=90.0°
1-Ferrocenyl-1-phenyl-2-methylpropan-1-ol
C20H22FeO
Acta Crystallographica Section B (1996) 52, 1 110-121
a=25.387(4)Å b=7.6825(6)Å c=17.803(3)Å
α=90.0° β=108.217(17)° γ=90.0°
Diferrocenyl(phenyl)methanol
C27H24Fe2O
Acta Crystallographica Section B (1996) 52, 1 110-121
a=9.3999(11)Å b=11.1988(16)Å c=11.9720(16)Å
α=117.844(11)° β=98.890(10)° γ=102.362(11)°
(Ferrocenylmethyl)trimethylammonium Iodide
C14H20NFeI
Acta Crystallographica Section B (1994) 50, 2 146-150
a=8.6236(5)Å b=13.5926(10)Å c=12.8623(6)Å
α=90° β=102.792(4)° γ=90°
Hexamethylferrocenediylbis(methylammonium iodide)
C18H30N2FeI2
Acta Crystallographica Section B (1994) 50, 2 146-150
a=27.1457(12)Å b=12.3446(6)Å c=14.5295(10)Å
α=90° β=115.909(4)° γ=90°
1-(2-Nitrophenylthio)-2,5-pyrrolidinedione
C10H8N2O4S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.918(5)Å b=13.132(5)Å c=10.983(5)Å
α=90.00° β=110.7(3)° γ=90.00°
S-(2-Nitrophenyl)benzenecarbothiolate
C13H9NO3S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.51(5)Å b=21.16(5)Å c=7.66(5)Å
α=90.00° β=92.043(10)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetra- azacyclotetradecane--terephthalic acid--water (1/1/4).
C16H38N4,C8H4O4,4H2O
Acta Crystallographica Section B (2000) 56, 1 85-93
a=13.3213(4)Å b=14.0499(4)Å c=16.0491(6)Å
α=90.00° β=110.549(2)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetra- azacyclotetradecane--terephthalic acid--water (1/1/6)
C16H38N4,C8H4O4,6H2O
Acta Crystallographica Section B (2000) 56, 1 85-93
a=8.1772(3)Å b=12.3974(4)Å c=16.8804(5)Å
α=90.00° β=116.231(2)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 2,2'-biphenol (1/2)
C16H38N42,2(C12H9O2)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.6323(19)Å b=9.943(3)Å c=12.582(2)Å
α=98.783(17)° β=102.785(15)° γ=115.746(11)°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-thiobiphenol-methanol (1/2/2)
C16H38N42,2(C12H9O2S),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=10.659(5)Å b=17.892(5)Å c=11.679(5)Å
α=90.00° β=103.107(5)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 3-hydroxybenzoic acid-methanol (1/2/2)
C16H38N42,2(C7H5O3),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.0814(9)Å b=10.1981(12)Å c=10.7800(16)Å
α=79.789(10)° β=80.728(10)° γ=80.280(10)°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-tsulfonylbiphenol-methanol (1/2/2)
C16H38N42,2(C12H9O4S),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=10.7736(10)Å b=18.1167(18)Å c=11.5532(14)Å
α=90.00° β=101.136(9)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- phenylphosphonic acid-water (1/4/2)
C16H40N44,4(C6H6O3P),2(H2O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.7391(2)Å b=26.1558(7)Å c=10.7871(2)Å
α=90.00° β=107.267(13)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4-hydroxybenzoic acid-methanol (1/2/1)
C16H38N42,2(C7H5O3),CH4O
Acta Crystallographica Section B (2000) 56, 1 39-57
a=9.4481(7)Å b=9.8905(6)Å c=18.0942(12)Å
α=88.704(5)° β=78.675(4)° γ=77.525(4)°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-biphenol (1/3)
C16H38N42,C12H10O2,2(C12H9O2)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=9.9634(10)Å b=18.8981(19)Å c=12.2344(11)Å
α=90.00° β=97.725(7)° γ=90.00°
(E)-1-(4-methyl-2-nitrobenzenethiolato)-2-phenylethene
C15H13NO2S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=21.595(3)Å b=14.518(2)Å c=7.9530(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(2-aminoethyl)amine-4,4'-sulfonyldiphenol (1/3)
2(C12H10O4S),C12H8O4S,C4H15N3
Acta Crystallographica Section B (2000) 56, 1 68-84
a=13.7305(5)Å b=14.9948(6)Å c=19.4209(9)Å
α=90.00° β=90.00° γ=90.00°
Bis(2-aminoethyl)amine--1,1,1-tris(4-hydroxyphenyl)ethane-- methanol (1/4/1)
4(C20H18O3),C4H13N3,CH4O
Acta Crystallographica Section B (2000) 56, 1 68-84
a=10.7171(9)Å b=11.2112(11)Å c=15.5547(19)Å
α=101.069(9)° β=92.924(9)° γ=97.291(9)°